EDGAR Filing Documents for 0001193125-17-136936

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-136936

Filing Date

2017-04-25

Accepted

2017-04-25 17:05:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d380004ds3.htm	S-3	440529
2	EX-4.3	d380004dex43.htm	EX-4.3	301046
3	EX-4.4	d380004dex44.htm	EX-4.4	109587
4	EX-4.5	d380004dex45.htm	EX-4.5	112406
5	EX-4.6	d380004dex46.htm	EX-4.6	91490
6	EX-5.1	d380004dex51.htm	EX-5.1	28468
7	EX-23.1	d380004dex231.htm	EX-23.1	1641
8	GRAPHIC	g380004g0425153600926.jpg	GRAPHIC	2869
9	GRAPHIC	g380004g0425153601082.jpg	GRAPHIC	2926
10	GRAPHIC	g380004g0425163024237.jpg	GRAPHIC	2722
	Complete submission text file	0001193125-17-136936.txt		1098568

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020

Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200

ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)